Literature DB >> 8359162

Multicentre evaluation of a biphasic culture system for recovery of mycobacteria from clinical specimens.

E Tortoli1, F Mandler, M Bartolucci, G Bertoli, D Costa, A Goglio, B Innocenti, C Lacchini, F Marchesani, C Passerini Tosi.   

Abstract

A new biphasic system (MB Check, Roche) for isolation of mycobacteria from clinical specimens was evaluated by eight different microbiological laboratories in comparison with methods routinely used in the respective laboratories. Altogether 1125 clinical specimens were processed; pretreatment, if performed, was by a variety of methods. Mycobacteria were recovered from 167 specimens with the biphasic system and 165 specimens with the other methods. The average time required for isolation of Mycobacterium tuberculosis was 22.6 days with the biphasic system and 24.7 days with egg-based media; for other mycobacterial species it was 23.5 versus 20.8 days. The inclusion of a chocolate agar section in the biphasic system facilitated the early detection of contaminants, while the NAP-containing section appeared unable to differentiate Mycobacterium tuberculosis from other mycobacterial species. The biphasic system, which enables recovery of mycobacteria in small laboratories without specialized equipment, is more practical than conventional methods and at least as sensitive.

Entities:  

Mesh:

Year:  1993        PMID: 8359162     DOI: 10.1007/bf01967436

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  2 in total

1.  Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria.

Authors:  H D Isenberg; R F D'Amato; L Heifets; P R Murray; M Scardamaglia; M C Jacobs; P Alperstein; A Niles
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

2.  Evaluation of a new biphasic culture system for the recovery of mycobacteria.

Authors:  T Giger; H J Burkardt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.